Samoa

Reimbursed Care Access

Samoa maintains a restrictive national drug framework based principally on the Narcotics Act (1967) and related medicines/food laws; most classical psychedelics and entheogens are listed as controlled substances with no authorised recreational or routine medical psychedelic programs. Medical use of standard anesthetic agents (e.g., ketamine) is regulated under Samoa’s medicines/health framework, but there is no evidence of a licensed, reimbursed medical psychedelic program (psilocybin/MDMA/5‑MeO‑DMT/etc.) or national reimbursement pathway for psychedelic-assisted psychotherapy as of the latest public legal texts and assessments.